» Articles » PMID: 36531435

Iron Deficiency and Blood Donation: Links, Risks and Management

Overview
Journal J Blood Med
Publisher Dove Medical Press
Specialty Hematology
Date 2022 Dec 19
PMID 36531435
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no harm. Iron deficiency without anemia (IDWA) and iron deficiency anemia (IDA) are common consequences of regular blood donation, and this activity is the most important factor affecting iron status in regular blood donors. Awareness of blood donation as a primary cause of sideropenia is surprisingly low among physicians. Blood donation screening identifies potential donors with IDA but is frequently inadequate to detect IDWA. For the assessment of body iron stores, plasma or serum ferritin, transferrin saturation (TSAT) and soluble transferrin receptors (sTfR) concentrations are the most widely used biochemical markers, although the percentage of hypochromic mature erythrocytes and the hemoglobin content of reticulocytes are also useful. IDWA can be prevented by limiting the total volume of blood collected, by iron deficiency screening and deferral of sideropenic donors, by prolonging the interdonation intervals, and by iron supplementation between donations. IDWA tends to be more prevalent in younger people, females, and high-intensity donors. A potentially effective strategy to address sideropenia in blood donors is serum ferritin testing, but this may lead to a higher rate of deferral. Most regular blood donors cannot replenish their iron deficit by an iron-rich diet alone and will benefit from low-dose oral iron administration with various commercially available products post-donation, a well-tolerated strategy. However, valid concerns exist regarding the possibility of worsening the iron overload in donors with undiagnosed hemochromatosis or masking the symptoms of a clinically important gastrointestinal hemorrhage or other underlying medical condition. Finally, educational efforts should be intensified to improve the awareness of blood donation as a primary cause of iron deficiency among physicians of all specialties.

Citing Articles

L-Arginine and Nitric Oxide in Vascular Regulation-Experimental Findings in the Context of Blood Donation.

Kurhaluk N, Tkaczenko H Nutrients. 2025; 17(4).

PMID: 40004994 PMC: 11858268. DOI: 10.3390/nu17040665.


Does young male need anemia screening? If yes, how it possible without cost?.

Mukhida S, Das N J Family Med Prim Care. 2024; 13(11):5421-5422.

PMID: 39722991 PMC: 11668428. DOI: 10.4103/jfmpc.jfmpc_599_24.


Impact of iron supplementation among anemic voluntary first-time blood donors: Results from the BLOODSAFE pilot trial in Ghana.

Dei-Adomakoh Y, Olayemi E, Telke S, Asamoah-Akuoko L, Appiah B, Segbefia C Transfusion. 2024; 65(1):131-139.

PMID: 39614766 PMC: 11750598. DOI: 10.1111/trf.18082.


Impact of Different Red Blood Cell Storage Solutions and Conditions on Cell Function and Viability: A Systematic Review.

Tran L, Gonzalez-Fernandez C, Gomez-Pastora J Biomolecules. 2024; 14(7.

PMID: 39062526 PMC: 11274915. DOI: 10.3390/biom14070813.


Blood donor biobank as a resource in personalised biomedical genetic research.

Clancy J, Ritari J, Vaittinen E, Arvas M, Tammi S, Koskela S Eur J Hum Genet. 2024; .

PMID: 38212662 DOI: 10.1038/s41431-023-01528-0.


References
1.
Aardal Eriksson E, Moback C, Jakobsson S, Hoffmann J . Iron depletion in blood donors - Have extended erythrocyte and reticulocyte parameters diagnostic utility?. Transfus Apher Sci. 2015; 53(1):76-81. DOI: 10.1016/j.transci.2015.03.011. View

2.
Mast A, Bialkowski W, Bryant B, Wright D, Birch R, Kiss J . A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion. 2016; 56(6 Pt 2):1588-97. PMC: 4905782. DOI: 10.1111/trf.13469. View

3.
Macher S, Herster C, Holter M, Moritz M, Matzhold E, Stojakovic T . The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT. Nutrients. 2020; 12(5). PMC: 7284357. DOI: 10.3390/nu12051313. View

4.
Gybel-Brask M, Seeberg J, Thomsen L, Johansson P . Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial. Transfusion. 2018; 58(4):974-981. DOI: 10.1111/trf.14521. View

5.
Cancado R, Chiattone C, Alonso F, Langhi Junior D, Alves R . Iron deficiency in blood donors. Sao Paulo Med J. 2001; 119(4):132-4; discussion 131. PMC: 11164459. DOI: 10.1590/s1516-31802001000400003. View